Your browser doesn't support javascript.
loading
Prevalence and Factors of Osteoporosis and High Risk of Osteoporotic Fracture in Patients with Ankylosing Spondylitis: A Multicenter Comparative Study of Bone Mineral Density and the Fracture Risk Assessment Tool.
Kim, Ji-Won; Park, Sunghoon; Jung, Ju-Yang; Kim, Hyoun-Ah; Kwon, Seong-Ryul; Choi, Sang Tae; Kim, Sung-Soo; Kim, Sang-Hyeon; Suh, Chang-Hee.
Afiliação
  • Kim JW; Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Park S; Department of Radiology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Jung JY; Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Kim HA; Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea.
  • Kwon SR; Division of Rheumatology, Department of Internal Medicine, InHa University College of Medicine, Incheon 22332, Korea.
  • Choi ST; Division of Rheumatology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul 06973, Korea.
  • Kim SS; Division of Rheumatology, Department of Internal Medicine, Kangneung Asan Medical Center, Ulsan University College of Medicine, Kangneung 25440, Korea.
  • Kim SH; Division of Rheumatology, Department of Internal Medicine, Keimyung University College of Medicine, Daegu 41931, Korea.
  • Suh CH; Department of Rheumatology, Ajou University School of Medicine, Suwon 16499, Korea.
J Clin Med ; 11(10)2022 May 17.
Article em En | MEDLINE | ID: mdl-35628957
ABSTRACT

BACKGROUND:

We investigated the prevalence of and the factors associated with a high risk of osteoporotic fractures in Korean patients with ankylosing spondylitis (AS).

METHODS:

This was a multicenter, retrospective study including 219 AS patients from five university hospitals; the control group was selected by matching age and sex with those of the AS patients. The fracture risk was evaluated based on bone mineral density (BMD) measured by dual-energy X-ray absorptiometry and the fracture risk assessment tool (FRAX) with/without BMD.

RESULTS:

The mean age of the patients was 47.6 years, and 144 (65.8%) patients were men. According to the WHO criteria and FRAX with/without BMD, the candidates for pharmacological treatment were 44 (20.1%), 20 (13.2%), and 23 (15.1%) patients, respectively, significantly more than those in the healthy control group. Among them, the proportion of patients receiving osteoporosis treatment was 39.1-75%. In logistic regression analysis, menopause was an independent factor for the high risk of fracture according to the WHO criteria and FRAX with/without BMD. C-reactive protein level (odds ratio (OR) 3.8 and OR 6) and glucocorticoid use (OR 1.5 and OR 1.7) were associated with a high risk of osteoporotic fracture based on FRAX without BMD and osteoporosis diagnosed according to the WHO criteria.

CONCLUSIONS:

Our study suggests that both FRAX and WHO criteria may be complementary for treatment decisions to reduce osteoporotic fractures in patients with AS.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article